Codexis to Participate in Cantor Global Healthcare Conference
Codexis (NASDAQ:CDXS), a provider of enzymatic solutions for therapeutic manufacturing, announced its participation in the upcoming Cantor Global Healthcare Conference. The event will take place from September 3-5, 2025, in New York.
The company's management will engage in a fireside chat on September 4, 2025, at 3:55 pm ET. Investors can access a live webcast through Codexis's investor relations website, with a replay available for 90 days after the event.
Codexis (NASDAQ:CDXS), fornitore di soluzioni enzimatiche per la produzione di terapie, ha confermato la propria partecipazione al Cantor Global Healthcare Conference. L'evento si terr脿 dal 3 al 5 settembre 2025 a New York.
La direzione dell'azienda parteciper脿 a un fireside chat il 4 settembre 2025 alle 15:55 ET. Gli investitori potranno seguire la diretta via webcast sul sito investor relations di Codexis; la registrazione rester脿 disponibile per 90 giorni dopo l'evento.
Codexis (NASDAQ:CDXS), proveedor de soluciones enzim谩ticas para la fabricaci贸n de terapias, ha anunciado su participaci贸n en el Cantor Global Healthcare Conference. El evento se celebrar谩 del 3 al 5 de septiembre de 2025 en Nueva York.
La direcci贸n de la compa帽铆a intervendr谩 en un fireside chat el 4 de septiembre de 2025 a las 3:55 pm ET. Los inversores podr谩n acceder a la retransmisi贸n en directo a trav茅s de la web de relaciones con inversores de Codexis; la grabaci贸n estar谩 disponible durante 90 d铆as tras el evento.
Codexis (NASDAQ:CDXS), 旃橂鞝� 鞝滌“毳� 鞙勴暅 須唽 靻旊（靺� 鞝滉车鞐呾泊臧� Cantor Global Healthcare Conference鞐� 彀胳棳頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟. 頄夓偓電� 2025雲� 9鞗� 3鞚茧秬韯� 5鞚缄箤歆� 雺挫殨鞐愳劀 臧滌禍霅╇媹雼�.
須岇偓鞚� 瓴届榿歆勳潃 2025雲� 9鞗� 4鞚� 鞓ろ泟 3鞁� 55攵�(霃欕秬鞁滉皠)鞐� 韺岇澊鞏挫偓鞚措摐 毂勴寘鞐� 彀胳棳頃╇媹雼�. 韴瀽鞛愲姅 Codexis 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼毳� 韱淀暣 霛检澊敫� 鞗轨簮鞀ろ姼毳� 鞁滌箔頃� 靾� 鞛堨溂氅�, 頄夓偓臧� 雭濍倻 頉� 90鞚� 霃欖晥 雼れ嫓氤搓赴臧� 鞝滉车霅╇媹雼�.
Codexis (NASDAQ:CDXS), fournisseur de solutions enzymatiques pour la fabrication de th茅rapies, a annonc茅 sa participation 脿 la Cantor Global Healthcare Conference. L'茅v茅nement se tiendra du 3 au 5 septembre 2025 脿 New York.
La direction de la soci茅t茅 participera 脿 un fireside chat le 4 septembre 2025 脿 15h55 ET. Les investisseurs pourront suivre la retransmission en direct via le site relations investisseurs de Codexis ; le replay sera disponible pendant 90 jours apr猫s l'茅v茅nement.
Codexis (NASDAQ:CDXS), Anbieter enzymatischer L枚sungen f眉r die therapeutische Herstellung, hat seine Teilnahme an der Cantor Global Healthcare Conference angek眉ndigt. Die Veranstaltung findet vom 3. bis 5. September 2025 in New York statt.
Das Management des Unternehmens wird am 4. September 2025 um 15:55 Uhr ET an einem Fireside-Chat teilnehmen. Investoren k枚nnen die Live-脺bertragung 眉ber die Investor-Relations-Website von Codexis verfolgen; eine Aufzeichnung steht 90 Tage nach der Veranstaltung zur Verf眉gung.
- None.
- None.
REDWOOD CITY, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS),听a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced the Company will attend the Cantor Global Healthcare Conference, being held September 3-5, 2025, in New York, New York.
Management will participate in a fireside chat on Thursday, September 4, 2025, at 3:55 pm ET. A live webcast of the event will be available in the Investor Relations section of the Company鈥檚 website,听. A replay will be archived for 90 days following the event.
About Codexis
Codexis is a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, leveraging its proprietary CodeEvolver庐听technology platform to discover, develop and enhance novel, high-performance enzymes. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis庐 manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis鈥� unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit听.
For More Information
Investor Contact
Georgia Erbez
650-421-8100
FAQ
When is Codexis (CDXS) presenting at the Cantor Global Healthcare Conference 2025?
How can investors watch Codexis's presentation at the Cantor Healthcare Conference?
Where is the 2025 Cantor Global Healthcare Conference being held?
What type of company is Codexis (CDXS)?
